If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
10.75    -0.30 (-2.71%)
Bid:
10.75
Ask:
11.55
Spread: 0.80 (7.442%)
Market Cap: £29.91m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

PORTFOLIO UPDATE

26 May 2017 07:26

RNS Number : 3271G
VPC Specialty Lending Invest. PLC
26 May 2017
 

26 May 2017

 

VPC Specialty Lending Investments PLC

(the "Company")

PORTFOLIO UPDATE

In line with the previously stated strategy of reallocating capital from market place lending to balance sheet lending, the Company is pleased to announce that it has sold the majority of its Funding Circle US and Upstart marketplace loans. The loans sold represented 3.65% and 1.48%, respectively, of the Company's NAV as at 31 March 2017. The impact of the two portfolio sales on the Company's NAV, which the Company estimates to be approximately -0.17%, will be reflected in the April NAV announcement. The Company will retain the non-performing Funding Circle US and Upstart loans, which represented 0.68% and 0.21% respectively of the Company's NAV as at 31 March 2017, and the Company has already been provisioned against these loans in line with the Company's reserving policy. The Company retired the leverage associated with the Upstart loans as part of the transaction, thereby reducing the Company gearing to 0.49x from 0.53x, on a pro forma basis at 31 March 2017.

These tactical sales help accelerate the Company's strategy of reallocating capital away from market place lending investments into balance sheet investments, which consistently have generated higher returns with less volatility. Taking into account the loan sales, the Company's balance sheet investments accounted for 63% of the NAV as at 31 March 2017, as compared to 17% for the marketplace loans. The Company expects to re-invest substantially all of the sale proceeds into balance sheet investments, as well as other strategic uses. The Company will continue to seek tactical opportunities to further reduce its exposure to market place loans where it is accretive to shareholder value.

The information contained in this announcement is inside information. 

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner, Investment Manager)

Cormac Leech (Principal)

 

via MHP (below)

Jefferies International Limited

Tel: +44 20 7029 8000

Gary Gould

Andrew MorrisAndrew Davison

Stifel Nicolas Europe Limited

Tel: +44 20 7710 7600

Neil Winward

Mark Bloomfield

Gaudi Le Roux

MHP (PR Adviser)

Tel: +44 20 3128 8100

Mark Lunn

Tim Rowntree

Kelsey Traynor

Email: vpc@mhpc.com

 

ABOUT VPC Specialty Lending Investments PLC:

VPC Specialty Lending Investments PLC invests in opportunities within the specialty lending market primarily through online lending platforms. The Company intends to generate an attractive total return for shareholders consisting of distributable income and capital growth via investments in a diverse portfolio of various platforms, asset classes, geographies (primarily U.S., U.K., Australia and Europe) and credit bands.

 

Since 2010, the Company's investment manager, VPC, has been actively involved in the specialty lending marketplace and has made more than $5.2 billion of investments and commitments across a number of financial technology platforms, multiple geographies (U.S., U.K., Australia and Europe), products (consumer and business) and structures (whole loans and senior credit facilities).

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialitylending.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUEAKSKAAAXEEF
Date   Source Headline
7th Mar 20183:15 pmRNSMonthly Report
7th Mar 20183:00 pmRNSNet Asset Value(s)
1st Mar 201811:28 amRNSTotal Voting Rights
1st Mar 20187:00 amRNSDividend Declaration
16th Feb 20187:00 amRNSQuarterly Letter
9th Feb 20184:35 pmRNSHolding(s) in Company
9th Feb 20189:41 amRNSDirector/PDMR Shareholding
8th Feb 20185:24 pmRNSTransaction in Own Shares
6th Feb 20183:15 pmRNSMonthly Report
6th Feb 20183:00 pmRNSNet Asset Value(s)
2nd Feb 20185:22 pmRNSTransaction in Own Shares
1st Feb 20189:51 amRNSTotal Voting Rights
30th Jan 20186:17 pmRNSTransaction in Own Shares
18th Jan 20185:29 pmRNSDirector/PDMR Shareholding
5th Jan 20183:15 pmRNSMonthly Report
5th Jan 20183:00 pmRNSNet Asset Value(s)
2nd Jan 20189:48 amRNSTotal Voting Rights
28th Dec 20175:09 pmRNSTransaction in Own Shares
27th Dec 20177:00 amRNSPortfolio Update
8th Dec 20175:26 pmRNSTransaction in Own Shares
7th Dec 20172:57 pmRNSDirector/PDMR Shareholding
7th Dec 20172:55 pmRNSDirector/PDMR Shareholding
6th Dec 20172:10 pmRNSDirector/PDMR Shareholding
5th Dec 20175:26 pmRNSTransaction in Own Shares
5th Dec 20173:35 pmRNSMonthly Report
5th Dec 20173:29 pmRNSNet Asset Value(s)
4th Dec 20175:12 pmRNSTransaction in Own Shares
1st Dec 201710:05 amRNSTotal Voting Rights
28th Nov 20175:37 pmRNSTransaction in Own Shares
24th Nov 20174:21 pmRNSHolding(s) in Company
23rd Nov 20175:21 pmRNSTransaction in Own Shares
22nd Nov 20175:32 pmRNSTransaction in Own Shares
21st Nov 20175:08 pmRNSTransaction in Own Shares
20th Nov 20175:51 pmRNSTransaction in Own Shares
16th Nov 20177:00 amRNSPortfolio Update
16th Nov 20177:00 amRNSDividend Declaration
14th Nov 20175:24 pmRNSTransaction in Own Shares
2nd Nov 20176:02 pmRNSTransaction in Own Shares
1st Nov 20175:41 pmRNSTransaction in Own Shares
1st Nov 20179:48 amRNSTotal Voting Rights
30th Oct 20175:08 pmRNSDirector/PDMR Shareholding
26th Oct 20173:15 pmRNSMonthly Report
26th Oct 20173:15 pmRNSQuarterly Letter
26th Oct 20173:00 pmRNSNet Asset Value(s)
24th Oct 20175:26 pmRNSTransaction in Own Shares
23rd Oct 20179:41 amRNSTransaction in Own Shares
23rd Oct 20177:00 amRNSPortfolio Update
18th Oct 20175:26 pmRNSTransaction in Own Shares
9th Oct 20175:01 pmRNSTransaction in Own Shares
9th Oct 20172:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.